Final answer:
Mestinon (pyridostigmine) or Neostigmine are the specific treatments given to patients with Myasthenia Gravis to improve neuromuscular conduction by increasing acetylcholine levels.
Step-by-step explanation:
For patients diagnosed with Myasthenia Gravis, the specific treatment that focuses on improving conduction at the neuromuscular junction is C. Mestinon (pyridostigmine) or Neostigmine. These medications work by inhibiting the breakdown of acetylcholine, thereby increasing the levels of acetylcholine at the neuromuscular junction and enhancing communication between nerve cells and muscles. This can lead to improved muscle strength and reduced weakness in patients with Myasthenia Gravis.